Brown Brothers Harriman & Co’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
VPM
VCM
B
Brown Brothers Harriman & Co's NEO Position: Q1 2026 in Review
Brown Brothers Harriman & Co sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 308 shares — an estimated $3.62K sold.
Brown Brothers Harriman & Co first reported a position in NEO in Q3 2019 and held it in 6 quarters. The position peaked at $19K in Q4 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Brown Brothers Harriman & Co reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
- Brown Brothers Harriman & Co sold 308 NeoGenomics shares in Q1 2026, an estimated $3.62K.
- Brown Brothers Harriman & Co first reported a position in NeoGenomics in Q3 2019 and held it in 6 quarters.
- Brown Brothers Harriman & Co's NeoGenomics position peaked at $19K in Q4 2019.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.